|
1
|
Peng W: Clinical observation of 86 cases
of early breast cancer conserving surgery. Contemporary Medicine.
1:107–108. 2012.
|
|
2
|
Jia ZC, Tian Y, Huang ZM, Wang JX, Fu XL,
Ni B and Wu YZ: Identification of a new MAGE-A10 antigenic peptide
presented by HLA-A*0201 on tumor cells. Cancer Biol Ther.
11:395–400. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Otte M, Zafrakas M, Riethdorf L,
Pichlmeier U, Löning T, Jänicke F and Pantel K: MAGE-A gene
expression pattern in primary breast cancer. Cancer Res.
61:6682–6687. 2001.PubMed/NCBI
|
|
4
|
Toso JF, Oei C, Oshidari F, Tartaglia J,
Paoletti E, Lyerly HK, Talib S and Weinhold KJ: MAGE-1-specific
precursor cytotoxic T-lymphocytes present among tumor-infiltrating
lymphocytes from a patient with breast cancer: characterization and
antigen-specific activation. Cancer Res. 56:16–20. 1996.PubMed/NCBI
|
|
5
|
Wolff AC, Hammond ME, Schwartz JN, Hagerty
KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer
A, et al: American Society of Clinical Oncology/College of American
Pathologists: American Society of Clinical Oncology/College of
American Pathologists guideline recommendations for human epidermal
growth factor receptor 2 testing in breast cancer. Arch Pathol Lab
Med. 131:18–43. 2007.PubMed/NCBI
|
|
6
|
Goodyear O, Agathanggelou A,
Novitzky-Basso I, Siddique S, McSkeane T, Ryan G, Vyas P, Cavenagh
J, Stankovic T, Moss P, et al: Induction of a CD8+
T-cell response to the MAGE cancer testis antigen by combined
treatment with azacitidine and sodium valproate in patients with
acute myeloid leukemia and myelodysplasia. Blood. 116:1908–1918.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lian Y, Sang M, Ding C, Zhou X, Fan X, Xu
Y, Lü W and Shan B: Expressions of MAGE-A10 and MAGE-A11 in breast
cancers and their prognostic significance: A retrospective clinical
study. J Cancer Res Clin Oncol. 138:519–527. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Riener MO, Wild PJ, Soll C, Knuth A, Jin
B, Jungbluth A, Hellerbrand C, Clavien PA, Moch H and Jochum W:
Frequent expression of the novel cancer testis antigen
MAGE-C2/CT-10 in hepatocellular carcinoma. Int J Cancer.
124:352–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Perez D, Hauswirth F, Jäger D, Metzger U,
Samartzis EP, Went P and Jungbluth A: Protein expression of cancer
testis antigens predicts tumor recurrence and treatment response to
imatinib in gastrointestinal stromal tumors. Int J Cancer.
128:2947–2952. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mei-Xing S, Bao-En S, Cui-Zhi G and Wei G:
Effect of melanoma antigen MAGE-A4 on the transcriptional activity
of p53. Tumors. 29:428–432. 2009.
|
|
11
|
Montoro JR, Mamede RC, Serafini L Neder,
Saggioro FP, Figueiredo DL, Silva WA Jr, Jungbluth AA, Spagnoli GC
and Zago MA: Expression of cancer-testis antigens MAGE-A4 and
MAGE-C1 in oral squamous cell carcinoma. Head Neck. 34:1123–1128.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sang M, Lian Y, Zhou X and Shan B: MAGE-A
family: Attractive targets for cancer immunotherapy. Vaccine.
29:8496–8500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sang M, Wang L, Ding C, Zhou X, Wang B,
Wang L, Lian Y and Shan B: Melanoma-associated antigen genes - an
update. Cancer Lett. 302:85–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ming M and Lizhang Y: The expression and
significance of tumor specific antigen MAGE gene. Foreign Medical
Sciences of Urinary System. 23:526–529. 2003.
|
|
15
|
Wu QR: Risks for breast cancer in chinese
female: a systematic review. Mod Prev Med. 38:61–72. 2011.(In
Chinese).
|
|
16
|
Osterlund C, Töhönen V, Forslund KO and
Nordqvist K: Mage-b4, a novel melanoma antigen (MAGE) gene
specifically expressed during germ cell differentiation. Cancer
Res. 60:1054–1061. 2000.PubMed/NCBI
|
|
17
|
Suzuki S, Sasajima K, Sato Y, Watanabe H,
Matsutani T, Iida S, Hosone M, Tsukui T, Maeda S, Shimizu K, et al:
MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in
patients with stomach cancer. Br J Cancer. 99:350–356. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang S, Zhou X, Yu H and Yu Y: Expression
of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer
tissues and cell lines. BMC Cancer. 10:1632010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang L, Li LD, Chen YD and Parkin DM: Time
trends, estimates and projects for breast cancer incidence and
mortality in China. Chin J Oncol. 28:438–440. 2006.(In
Chinese).
|
|
20
|
Schrauder MG, Fasching PA, Häberle L, Lux
MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD,
et al: Diabetes and prognosis in a breast cancer cohort. J Cancer
Res Clin Oncol. 137:975–983. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu Z, Liu Z and Yu K: The clinical
features and prognosis of patients with type 2 diabetes in breast
cancer patients. China. J Cancer. 6:466–470. 2010.(In Chinese).
|
|
22
|
Canzian F, Cox DG, Setiawan VW, Stram DO,
Ziegler RG, Dossus L, Beckmann L, Blanché H, Barricarte A, Berg CD,
et al: Comprehensive analysis of common genetic variation in 61
genes related to steroid hormone and insulin-like growth factor-I
metabolism and breast cancer risk in the NCI breast and prostate
cancer cohort consortium. Hum Mol Genet. 19:3873–3884. 2010.
View Article : Google Scholar : PubMed/NCBI
|
